These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 71274)

  • 61. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.
    Linzer DI; Levine AJ
    Cell; 1979 May; 17(1):43-52. PubMed ID: 222475
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Immunization of hamsters against tumors induced by the SV40 virus].
    Ciobanu Z; Fenyves A
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):109-16. PubMed ID: 4328000
    [No Abstract]   [Full Text] [Related]  

  • 63. Apparent absence of virus-specific transplantation rejection antigen in herpes simplex virus-transformed hamster cells.
    Lausch RN; Hay KA
    IARC Sci Publ (1971); 1978; (24 Pt 2):905-10. PubMed ID: 87369
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Surface antigens of BK virus-induced tumor cells.
    Karjalainen HE
    Med Biol; 1981 Feb; 59(1):35-40. PubMed ID: 6267387
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vivo blocking of SV40 virus-induced antitumor resistance by Syrian hamster sera from early stages of primary SV40 carcinogenesis.
    Volpe EA
    Neoplasma; 1976; 23(4):345-53. PubMed ID: 187966
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Two adenovirus type 2-simian virus 40 hybrid populations that contain the entire SV40 genome differ in their ability to induce SV40 transplantation immunity in hamsters but not in mice.
    Tevethia SS; Lewis AM
    J Virol; 1976 Nov; 20(2):539-42. PubMed ID: 185429
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The importance of dose and proliferation of SV40-transformed cells with different oncogenic potentials to the level of tumor immunity.
    Stillström J
    Int J Cancer; 1974 Mar; 13(3):273-85. PubMed ID: 4362607
    [No Abstract]   [Full Text] [Related]  

  • 68. Demonstration of multiple antigenic sites of the SV40 transplantation rejection antigen by using cytotoxic T lymphocyte clones.
    Campbell AE; Foley FL; Tevethia SS
    J Immunol; 1983 Jan; 130(1):490-2. PubMed ID: 6183360
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of long-lived germinal centers associated with persisting antigen after viral infection.
    Bachmann MF; Odermatt B; Hengartner H; Zinkernagel RM
    J Exp Med; 1996 May; 183(5):2259-69. PubMed ID: 8642335
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunoprecipitating human antigens associated with vesicular stomatitis virus grown in HeLa cells.
    Little LM; Lanman G; Huang AS
    Virology; 1983 Aug; 129(1):127-36. PubMed ID: 6310874
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.
    Kahn JS; Roberts A; Weibel C; Buonocore L; Rose JK
    J Virol; 2001 Nov; 75(22):11079-87. PubMed ID: 11602747
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inability of antiserum active in antibody-dependent cellular cytotoxicity and arming tests to protect against simian virus 40 tumor cell challenge.
    Prather SO; Geller RW; Lausch RN
    J Natl Cancer Inst; 1979 May; 62(5):1273-7. PubMed ID: 220449
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunogenic properties of a soluble tumor rejection antigen (TSTA) from a Simian virus 40-induced sarcoma.
    Rogers MJ; Law LW
    Int J Cancer; 1979 Jan; 23(1):89-96. PubMed ID: 83307
    [No Abstract]   [Full Text] [Related]  

  • 74. The immunopathology of SV40-induced transformation.
    Mora PT
    Springer Semin Immunopathol; 1982; 5(1):7-32. PubMed ID: 6314571
    [No Abstract]   [Full Text] [Related]  

  • 75. Interactions of vesicular stomatitis virus with murine cell surface antigens.
    Hecht TT; Summers DF
    J Virol; 1976 Sep; 19(3):833-45. PubMed ID: 61285
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro transformation by adenovirus-simiam virus 40 hybrid viruses. IV. Properties of clones isolated from cell lines transformed by adenovirus 2-simiam virus 40 and adenovirus 12-simiam virus 40 transcapsidant hybird viruses.
    Black PH; Berman LD; Dixon CB
    J Virol; 1969 Nov; 4(5):694-703. PubMed ID: 4311797
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Presence of allograft-rejection resistance in simian virus 40-transformed hamster cells and its possible role in tumor development.
    Lewis AM; Cook JL
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2886-9. PubMed ID: 6248874
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Biology of SV40 transplantation antigen (TrAg). I. Demonstration of SV40 TrAg on glutaraldehyde-fixed SV40-infected African green monkey kidney cells.
    Tevethia MJ; Tevethia SS
    Virology; 1976 Feb; 69(2):474-89. PubMed ID: 176782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.